Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renexin CR in acute non-cardioembolic ischemic stroke
NCT05445895Phase 4Completed
- Sponsor
- SK Chemicals
- Start
- Dec 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol + ginkgo leaf extract in ischemic stroke, sponsored by SK Chemicals. Started Dec 2022; status: completed.
02
Drugs
cilostazol + ginkgo leaf extract
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05445895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05445895.